By Tom Zanki ( February 5, 2015, 3:19 PM EST) -- Animal medicine developer Nexvet Biopharma PLC priced an initial public offering below range Thursday, raising about $40 million, and watched shares slide further in debut trading, the latest in a flurry of life science IPOs on a rocky day that saw another company postpone plans....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.